Is EUDA Health Holdings Limited Ordinary Shares a good investment? EUDA Health Holdings Limited Ordinary Shares (EUDA) is currently trading at 9.40 USD.
In terms of valuation, the stock trades at a P/E ratio of 27.25. This valuation is generally in line with the broader market.
Earnings Schedule: EUDA Health Holdings Limited Ordinary Shares is expected to release its next earnings report on May 5, 2026. The market consensus estimate for Forward EPS is 1.60.
No, it does not currently pay a dividend.
EUDA Health Holdings Limited Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be May 5, 2026. The company currently has a trailing EPS of 0.40.
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.
| Split Date | Split Ratio to 1 |
|---|---|
| March 23, 2026 | 0.050000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion